| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.05 |